Cara Therapeutics: CHMP Recommends Approval Of Kapruvia
25/2 13:54
(RTTNews) - Vifor Fresenius Medical Care Renal Pharma and Cara Therapeutics, Inc. (CARA) announced that the European Medicines Agency's CHMP has recommended approval of Kapruvia for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in hemodialysi...